Brief: Protalix Biotherapeutics Appoints Eliot Richard Forster, Ph.D. As Chairman Of Its Board Of Directors
12/09/2023 12:02
Immatics NV 4A3.F :
* PROTALIX BIOTHERAPEUTICS APPOINTS ELIOT RICHARD FORSTER,
PH.D.
AS CHAIRMAN OF ITS BOARD OF DIRECTORS
* PROTALIX BIOTHERAPEUTICS INC - ZEEV BRONFELD TO RETIRE
FROM
BOARD OF DIRECTORS
Source text for Eikon: ID:nPn3hxWnra
Further company coverage: 4A3.F
Recent news on Protalix BioTherapeutics
See all newsIsrael's Protalix Q2 revenue rises on Elfabrio sales, reiterates 2026 outlook
Israel's Protalix Q1 revenue surges on Chiesi milestone
Brief: Protalix BioTherapeutics Q1 EPS USD 0.23
Brief: Protalix Biotherapeutics Reports Fiscal Year 2025 Financial And Business Results
Brief: EU Approves Four‑week Dosing Option For Chiesi and Protalix’s Elfabrio